Publications

You can use the filters to show only results that match your interests

Filter publications
412 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients

  2. Medicines and Healthcare products Regulatory Agency board member expenses from January to March 2018

    • MHRA
    • Transparency data
  3. Proposal to make Colourstart Test 65mcg Cutaneous Patch available from general sales outlets without prescription

    • MHRA
    • Open consultation
  4. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  5. Marketing authorisations granted in September 2018

  6. Parallel import licenses granted in September 2018

  7. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  8. Medicines: new manufacturing and wholesale dealer licences

  9. Register of brokers authorised to deal in human medicines

  10. Human and veterinary medicines: register of licensed wholesale distribution sites

  11. Human and veterinary medicines: register of licensed manufacturing sites

  12. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  13. MHRA consultation on EU exit no-deal legislative proposals

    • MHRA
    • Open consultation
  14. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  15. Parallel import licenses granted in August 2018

  16. Marketing authorisations granted in August 2018

  17. Advertising investigations: August 2018

  18. Medicines and Healthcare products Regulatory Agency Privacy Notice

    • MHRA
    • Transparency data
  19. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  20. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2018 to 2019

    • MHRA
    • Transparency data
  21. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2017 to 2018

    • MHRA
    • Transparency data
  22. Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2018 - 2019

    • MHRA
    • Transparency data
  23. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  24. MHRA: requests under the Freedom of Information Act (FOIA)

    • MHRA
    • FOI release
  25. Parallel import licenses granted in July 2018

  26. Marketing authorisations granted in July 2018

  27. Assistive technology: definition and safe use

  28. Implementation period: what it means for the life sciences sector

    • DHSC, VMD and MHRA
    • Guidance
  29. Medical devices: UK notified bodies

  30. MHRA fees

    • MHRA
    • Statutory guidance
  31. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2017 to 2018

    • MHRA
    • Corporate report
  32. Implementing ‘safety features’ under the Falsified Medicines Directive

    • MHRA
    • Closed consultation
  33. Annual review of good clinical practice referrals

    • MHRA
    • Official Statistics
  34. Marketing authorisations granted in June 2018

  35. Parallel import licenses granted in June 2018

  36. Common issues identified during clinical trial applications

    • MHRA
    • Guidance
  37. MHRA: business impact target

    • MHRA
    • Research and analysis
  38. Advertising investigations: May 2018

  39. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  40. Medical devices: software applications (apps)